Literature DB >> 16425579

Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort.

M Petri1.   

Abstract

The Hopkins Lupus Cohort is a prospective longitudinal study of lupus activity, organ damage, and quality of life in SLE patients. It is balanced between Caucasian and African-American SLE patients. This review highlights major findings from the cohort with implications for clinical care.

Entities:  

Mesh：

Year:  2005        PMID： 16425579     DOI： 10.1191/0961203305lu2230xx

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  13 in total

1.  Top 10 clinical research developments in antiphospholipid syndrome.

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

2.  Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.

Authors:  R Willis; A M Seif; G McGwin; L A Martinez-Martinez; E B González; N Dang; E Papalardo; J Liu; L M Vilá; J D Reveille; G S Alarcón; S S Pierangeli
Journal:  Lupus       Date:  2012-02-17       Impact factor: 2.911

3.  Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.

Authors:  Yan Zhang; Celia P Corona-Villalobos; Adnan N Kiani; John Eng; Ihab R Kamel; Stefan L Zimmerman; Michelle Petri
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-29       Impact factor: 2.357

Review 4.  Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

5.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

6.  Prednisone, lupus activity, and permanent organ damage.

Authors:  Mae Thamer; Miguel A Hernán; Yi Zhang; Dennis Cotter; Michelle Petri
Journal:  J Rheumatol       Date:  2009-02-04       Impact factor: 4.666

7.  Increased risk of death in African American patients with end-stage renal disease secondary to lupus.

Authors:  Sangeeta Sule; Barbara Fivush; Alicia Neu; Susan Furth
Journal:  Clin Kidney J       Date:  2014-01-02

Review 8.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

Review 9.  Lupus Cohorts.

Authors:  Christopher Redmond; Omer Pamuk; Sarfaraz A Hasni
Journal:  Rheum Dis Clin North Am       Date:  2021-06-10       Impact factor: 2.032

10.  Controversies in the antiphospholipid syndrome: can we ever stop warfarin?

Authors:  Ana G Fonseca; David P D'Cruz
Journal:  J Autoimmune Dis       Date:  2008-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.